Medication info
Glucophage 500 mg (Metformin Hydrochloride)

Glucophage 500 mg (Metformin Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Yuyu Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet engraved with the letter 'M' on one side and the number '500' on the other side.
Packaging
90 tablets (15 tablets/PTPX6), 500 tablets/bottle
Approval status
Active

MFDS item code 200401015 · Notified 2004.03.03 · Insurance code 644501350

Summary

Main use
Treatment of type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
The dose should be determined individually based on drug response and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate blood glucose control, treatment with this medicine must be initiated at a low dose: administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 administrations daily with meals; the maximum daily dose is 2550mg. At the start of treatment and when adjusting the dose, fasting blood glucose should be measured to assess the therapeutic response to this medicine and identify the minimum effective dose. Blood glycosylated hemoglobin levels should be measured approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose had been controlled with diet therapy alone, short-term treatment with this medicine may be sufficient to achieve an adequate effect. This medicine may be used, with the following dose adjustments, in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine must be discontinued immediately.
Child dose
Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Ingredients

Manufacturer
Yuyu Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of type 2 diabetes mellitus

  • Type 2 diabetes with insufficient blood sugar control
View approved original text

This medication is used for the treatment of patients with type 2 diabetes who do not have sufficient blood sugar control with diet and exercise. It is particularly effective for overweight diabetic patients, and can be used alone or in combination with other oral hypoglycemic agents or insulin in adults. Additionally, it can be used as a monotherapy or in combination with insulin in children aged 10 and older and adolescents, making it suitable for patients of various ages. This drug helps to control blood sugar levels and aids in diabetes management.

How to take

Adult dose

The dose should be determined individually based on drug response and tolerability, and should not exceed the recommended maximum daily dose. To reduce gastrointestinal adverse reactions and identify the minimum dose required for adequate blood glucose control, treatment with this medicine must be initiated at a low dose: administer 500mg per dose 2~3 times daily with meals. Increase the dose gradually by 500mg each week. When taking up to 2000mg, the dose is usually divided into 2 doses daily, in the morning and evening. For doses exceeding 2000mg, divide the dose into 3 administrations daily with meals; the maximum daily dose is 2550mg. At the start of treatment and when adjusting the dose, fasting blood glucose should be measured to assess the therapeutic response to this medicine and identify the minimum effective dose. Blood glycosylated hemoglobin levels should be measured approximately every 3 months. The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycosylated hemoglobin levels to normal or near-normal levels using the minimum effective dose. In general, when blood glucose is temporarily uncontrolled in patients whose blood glucose had been controlled with diet therapy alone, short-term treatment with this medicine may be sufficient to achieve an adequate effect. This medicine may be used, with the following dose adjustments, in patients with moderate renal impairment at stage 3a (creatinine clearance [CrCl] 45≤~<60ml/min or glomerular filtration rate (GFR) 45≤~<60mL/min/1.73㎡) who do not have other conditions that may increase the risk of lactic acidosis. - The starting dose is 500mg or 850mg once daily. The maximum daily dose is 1000mg, divided into 2 doses. Renal function should be closely monitored every 3-6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73㎡, respectively, treatment with this medicine must be discontinued immediately.

Child dose

Children aged 10 years and older or adolescents who are still growing: The usual starting dose is 500 milligrams once daily, administered during or after a meal. Blood glucose levels should be measured after one week and the dose adjusted accordingly. Gastrointestinal adverse effects may improve with gradual dose increases. The maximum daily dose is 2000mg. Divide this dose into 2~3 administrations.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so it should be used with great caution. It should not be administered to patients with moderate to severe renal impairment or those in acute situations such as dehydration, severe infections, or heart disease. Especially, the use of this drug should be discontinued before and after examinations utilizing iodinated contrast media, and it should be resumed only after reevaluating kidney function. Patients with hypersensitivity to this drug, as well as those with type 1 diabetes, diabetic ketoacidosis, severe infections, or severe trauma should avoid its use. If undergoing surgery, it should be temporarily discontinued 48 hours before the procedure, and it can be restarted only after confirming normal kidney function. Caution is also needed in patients with malnutrition, starvation, weakness, liver dysfunction, pulmonary dysfunction, or excessive alcohol consumption. During treatment with this drug, irregular meals or intense exercise, as well as the intake of interacting medications may pose risks of lactic acidosis and hypoglycemia, so careful management is necessary. Although lactic acidosis is very rare, it can be a fatal side effect. If symptoms such as malaise, muscle pain, shortness of breath, weakness, or abdominal pain appear, a doctor should be notified immediately. Gastrointestinal symptoms commonly include diarrhea, nausea, vomiting, and abdominal bloating, usually transient at first. Since this drug is excreted through the kidneys, it is necessary to regularly monitor kidney function and adjust the dose or discontinue treatment if abnormalities are found. Alcohol can affect the lactate metabolism of this drug and increase the risk of lactic acidosis, so excessive drinking should be avoided. There is a risk of vitamin B12 deficiency, so it is advisable to regularly check blood vitamin B12 levels. Hypoglycemia is rare when used alone but can occur if combined with other hypoglycemic agents or in cases of poor nutritional status, so caution is warranted. During pregnancy, this drug can cross the placenta and may affect fetal growth, therefore it should not be used if there is a risk of placental insufficiency or preeclampsia. While breastfeeding, this medication is secreted into breast milk and may affect newborns; therefore, the decision regarding breastfeeding and drug therapy should be made carefully. In elderly patients, renal function decline is common, so dosage adjustments and frequent monitoring of kidney function are required. There are many drug interactions, so when taking other medications, blood sugar and kidney function should be closely monitored. In case of overdose, hypoglycemia is rare, but there may be a risk of lactic acidosis, and appropriate measures such as hemodialysis may be required. This drug helps in controlling blood sugar without causing weight gain, and if used in children or adolescents, growth and development should be closely monitored. Regular blood sugar, kidney function, blood tests, and symptom monitoring should always be thoroughly conducted while taking this medication to ensure safe treatment.

Side effects

  • Lactic acidosis
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
  • metallic taste
Show 7 more
  • rash
  • anemia
  • leukopenia
  • thrombocytopenia
  • vitamin B12 deficiency
  • liver dysfunction
  • severe delayed hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain the storage temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy and safety of the medication for a long time.

Appearance and packaging

Appearance

White round film-coated tablet engraved with the letter 'M' on one side and the number '500' on the other side.

Package unit

90 tablets (15 tablets/PTPX6), 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.